effect of meloxib & physiotherapy in TMD
Phase 3
- Conditions
- temporomandibulr disorder.
- Registration Number
- IRCT20181113041642N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Patients with a history of myofacial pain of TMD
Both sexes
Aged 15-60 years
Exclusion Criteria
Arthritis and other systemic joint diseases
Articular dislocation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Masticatory muscles tenderness. Timepoint: First and last day (30) of study. Method of measurement: questionnaire and examination.;Joint sounds. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.;Mouth opening limitation. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.;Subluxation. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.;Deviation. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.;Limitation on lateral movement. Timepoint: first and last day of study. Method of measurement: questionnaire and examination.
- Secondary Outcome Measures
Name Time Method